Aktieselskabet Schouw & Co.
Schouw & Co. share buy-back programme, week 45 2025
Schouw & Co. share buy-back programme, week 45 2025
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount | ||
| Accumulated until 31 October 2025 | 168,600 | 599.12 | 101,012,339 | ||
| Monday, 3 November 2025 | 1,300 | 595.23 | 773,799 | ||
| Tuesday, 4 November 2025 | 1,300 | 584.77 | 760,201 | ||
| Wednesday, 5 November 2025 | 1,400 | 581.67 | 814,338 | ||
| Thursday, 6 November 2025 | 1,400 | 579.00 | 810,600 | ||
| Friday, 7 November 2025 | 1,400 | 575.36 | 805,504 | ||
| In the period 3 November 2025 - 7 November 2025 | 6,800 | 583.01 | 3,964,442 | ||
| Accumulated until 7 November 2025 | 175,400 | 598.50 | 104,976,781 | ||
| Following the above transactions, Schouw & Co. holds a total of 2,217,393 treasury shares corresponding to 8.87% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Evosep10.11.2025 15:00:00 CET | Press release
Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics
Pandora A/S10.11.2025 14:34:12 CET | Press release
Transactions in connection with share buyback programme
Azurity Pharmaceuticals10.11.2025 14:30:00 CET | Press release
Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility
Freshworks Inc10.11.2025 14:00:00 CET | Press release
20% of Software Budgets Wasted on Unnecessary Business Complexity, Freshworks Survey Finds
VoltaGrid LLC10.11.2025 14:00:00 CET | Press release
VoltaGrid Closes $5.0 Billion Comprehensive Financing Package Consisting of $2.0 Billion of Senior Secured Second Lien Notes and $3.0 Billion Asset-Based Loan Facility
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom